2020 Central region candidates
Candidates are listed alphabetically by last name.
Professor, University of Cape Town, South Africa
I am the South African Research Chair in Applied & Chemical Proteomics at the University of Cape Town, Deputy Director of the Institute of Infectious Disease & Molecular Medicine, and Head, Division of Chemical & Systems Biology. I am also Chief Scientific Officer of Sengenics Corporation (Singapore), a functional proteomics company.
I serve on the Foundation for the National Institutes of Health’s Biomarker Consortium steering committees for Cancer, Neuroscience and Inflammation & Immunity; HUPO’s IAB; and an RSA government Covid-19 Research & Innovation Advisory Committee. I am Chair of the Proteomics & Metabolomics Working Group (‘DIPLOMICS’ initiative, RSA) which aims to build the local proteomics community and infrastructure, as well as to promote and enable proteomics research in RSA.
My proteomics research programs include: mechanistic studies on tuberculosis disease, HIVassociated TB immune reconstitution inflammatory syndrome & HIV-associated neurocognitive disorders; discovery and validation of diagnostic urinary biomarkers of TB disease, schistosomiasis, Covid-19 and prostate cancer; & identification of microbial effectors in gut microbiomes of HIVexposed infants through metaproteomics. I also use our leading protein microarray platform to identify autoantibody profiles in cancer and autoimmune disease that predict response to treatment and risk of immune-related adverse events.
These research programs focus on diseases that are prevalent on the African continent and aim to identify and translate diagnostic and prognostic biomarkers for use in low resource settings in the developing world. I have trained many postdoctoral (27; 8 current), doctoral (30; 14 current) and Masters (15; 6 current) students from across the African continent, including a large number of black African students and postdocs from Nigeria, Cameroon, DRC, Zimbabwe, Malawi, Madagascar and Ethiopia, as well as South Africa.
If elected as a HUPO Councillor, I believe that I will be therefore very well placed to transparently represent and support a black African constituency.
Professor and Head of the UCM Proteomics Unit, Complutense University, Spain
Dr. Concha Gil is Professor of Microbiology and Scientific Coordinator of the Proteomics Unit at the Complutense University. During the period 2015-2019 she has coordinated the 17 Research Support Centers of UCM (https://www.ucm.es/english/research-support-centres). She leads the group “Host pathogen interaction. Human Proteome Project” (http://www.ucm.es/candida).
She was co-founder of SEPROT (Spanish Proteomics Society) in 2004, and of EuPA (European Proteomics Association) in 2005. She has been Coordinator of the Educational Committee (2005-2008) and of the Communication and Conference Committee (2009-2011) within EuPA. Since 2014 is again an active member of the Communication and Conference Committee (https://eupa.org/). Co-chair of the HUPO HPP-Infectious Diseases Initiative (https://www.hupo.org/Infectious-Disease-Initiative), member of the HUPO Publications Committee (2018-2019) and member of the Awards Committee (2018-2020) (https://www.hupo.org/HUPO-Committees). She belongs to ProteoRed (a Spanish network for the coordination and development of proteomics facilities) and to the Spanish Chromosome-16 HPP (Human Proteome Project) Consortium (https://www.proteored.org/).
Her research activity is focus on proteomics, on host-pathogen interaction and on the development of new strategies for the diagnosis of invasive fungal diseases. She has published over 110 articles in peer reviewed journals (Research ID F-6470-2015; ORCID 0000-0003-3137-2600; h-index 34) and she has directed 20 national, 2 international projects, 20 Doctoral Theses and 10 Master projects.
Ole Nørregaard Jensen
Professor, University of Southern Denmark, Denmark
Prof. Ole N. Jensen is a long time member of HUPO and an experienced member of the HUPO Council. He contributed to the HUPO education and training program in the period 2006-2010, including HUPO Practical Courses in protein mass spectrometry and proteomics in his laboratory at SDU in Odense, Denmark.
Ole N. Jensen has authored more that 300 scientific papers in the fields of biological mass spectrometry, protein science and proteomics. He pioneered a series of bioanalytical methods for detailed investigations of protein-nucleic acid complexes, protein phosphorylation and cell signaling events, and epigenetic regulatory mechanisms by using advanced mass spectrometry technology and associated bioinformatics tools. Current research is focused on chromatin biology and mass spectrometry technology for elucidating the many roles of post-translational modifications in regulation of biological functions in health and disease.
Ole N. Jensen is Director of the VILLUM Center for Bioanalytical Sciences at SDU and Director of the Danish National Mass Spectrometry Platform for Functional Proteomics, PRO-MS. He was recently awarded the EuPA Juan Pablo Albar Proteomics Pioneer Award and the MCP Lectureship Award.
Ole N. Jensen has supervised and mentored more than 50 PhD students and postdocs who have moved on to successful careers in academia and industry in Denmark and abroad.
Professor of Proteomics, University College Dublin, Ireland
Steve is Professor of Proteomics in UCD. A chemist (Imperial College, London) and PhD biochemist (University of Cambridge) by training. He has spent much of his research career using mass spectrometry to measure and characterise proteins. Steve has given over 150 invited presentations at international events, published over 75 scientific papers as well as editing and contributing to several books including editing one of the first books on Proteomics that was translated into Chinese and Japanese.
Steve has been active, including roles as a committee member, in the British Society for Proteome Research for which he is currently President, and the European Proteomics Association. He was the lead organiser of 16th Human Proteome Organisation (HUPO) World Congress held in the national Convention Centre in Dublin from 17-20th September 2017; organised the HUPO Gala Dinner 2017 with guest of honour Joe Biden and is currently President of HUPO.
Steve is committed to raising public awareness of the vital role of proteomics in endeavours to improve human health.
Associate Professor, University Magna Graecia of Catanzaro, Italy
I have been a member of the Council HUPO since 2015, where I have always pushed to give voice to the issues of proteomics applied to food, nutrition. Moreover, I strongly encourage the young investigator's program and the application of proteomics methodologies to deal with antibiotic resistance, the study of allergens and food microbiota to ensure food safety. I am the co-funder of Mt-HPP action in Human Proteome Project (Boston, 2012) and I founded the Food and Nutrition proteomics action, which is part of HPP program, organizing annual meetings in Italy and organizing sessions in the HUPO congress, where I have always attended since 2012. This action was formerly approved also inside the European proteomics Association so I was able to push exchange of ideas and program between the two communities. I also serve as Executive Editor fo Journal of Proteomics in the field of food science and nutrition. Since I am the current President of Italian proteomics association, for me is simple to activate training program and exchange program within the young investigators inside HUPO community.
If my candidacy is successful, my duty will be to be active in the dissemination of proteomics in public health areas, from animal health to zoonese, to antibiotic resistance till food safety. My commitment will also to attract young investigators of all scientific disciplines to actively participate in HUPO community.
Associate in Translational Proteomics, KTH Royal Institute of Technology, Sweden
Over the last years, I have represented the Human Antibody Initiative in the HPP executive committee and served as chair of the Human Plasma Proteome Project.
My duties have given me insights into the HUPO organization, and I embrace the vision to build a proteomics community as well as to bring forward the HPP. To take the next steps, I believe that we need to continue with bringing in engagements from different fields, technologies and perspectives. As an organization, we need to continue to prioritize diversity and keep our doors open for others to feel invited to the HUPO network. HUPO already excellently acknowledges early career excellence and life-time achievements, but it will also be good to support the broad group of mid-career scientist, who will become the next-generation leaders in proteomics.
It will also be exciting to see how proteomics will contribute to a better clinical care. Indeed, the recent advances in plasma proteomics using mass spectrometry and affinity proteomics have again increased the attention to clinical utility of blood protein analysis. We can witness how technology development and new approaches on data analysis and integration can address the unmet clinical needs beyond other types of omics.
As a member of the HUPO council, I will contribute with my knowledge and perspectives on proteomics, the insights from working on trans-disciplinary efforts, and on strategies using affinity proteomics. My vision is to make HUPO an open and strong organization with experts from inside and outside of the community.
PhD, CAE- BioHealth department, France
During my career, I had the privilege to work both in academia and in a biotechnology company, and to bridge disciplines: from Physiology and Cellular biology to Bioinformatics, and from Genomics to Proteomics. Since 2010, I am a PI at the Health Department of the CEA in Grenoble (France), collaborating with data scientists, biologists and clinicians, in association with a prominent proteomics infrastructure. My research focuses on designing bioinformatics tools and strategies to leverage the ever-increasing wealth and diversity of proteomics data for biomarkers discovery, and for the elucidation of biological processes underlying human diseases. I served on the Executive Committee of the French Proteomics Society for eight years. As training manager of the French Proteomics Infrastructure, I organized practical sessions in computational proteomics for young as well as experienced researchers. I contribute to tutorials via the Galaxy Training Network and to the European Elixir proteomics community, participating in the dissemination of proteomics data analysis pipelines.
For many years, I have taken part in HUPO initiatives such as standard data formats within the HUPO-PSI, as co-PI of the c-HPP, co-founder and co-organizer of the “Bioinformatics Hub” and, more recently, as member of the HUPO awards committee. I hereby apply to the HUPO council to continue promoting the use of computational proteomics resources (data, tools, workflows), and facilitate their accessibility to non-expert users. I am convinced that informal exchange of ideas and interactions between dry and wet lab scientists through dedicated events like the “Bioinformatics Hub” are essential to tackle tomorrow’s challenges. Through my involvement in these community efforts, I will contribute to initiatives that stimulate excitement for proteomics and extend the outreach of HUPO towards the broader scientific community.
James C. Waddington
Post Doctoral Research Fellow, University College Dublin, Ireland
Having joined HUPO at the beginning of my PhD, I have continued to be an active member of HUPO and the wider proteomics community. For the past 2+ years I been a management committee member for the UK proteomics society (BSPR), participating in conference organization and promotion of the society. More recently, I have been effectively engaging with members of the HUPO executive committee and council, in the generation of interactive educational tools to coincide with the release of the HPP decadal review. Throughout my career, I have worked in a diverse team both at a national and international level. Having witnessed first-hand the importance and power of collaborative engagement, I believe I can contribute to the progression of the proteomics community. As a member of the HUPO council, I would offer both enthusiasm and professionalism, advancing my past experiences and knowledge to continue the growth and success of the society.